Business
Assertio to Participate in the 2022 Lake Street BIG6 Conference
LAKE FOREST, Ill., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (Nasdaq: ASRT), a specialty pharmaceutical company
About this update from Assertio Holdings, Inc.
[{"type":"text","content":"LAKE FOREST, Ill., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (\"Assertio\" or the \"Company\") (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that Dan Peisert, CEO, will host investor meetings September 14, 2022 as part of the Lake Street Capital Markets Best Ideas Growth Conference (BIG6), taking place at The Yale Club in New York City. As part of the conference event, management will host one-on-one meetings throughout the day. For more information about scheduling a one-on-one meeting with management, please contact your Lake Street representative or Matt Kreps, Investor Relations for Assertio Holdings, at [email protected]. About Assertio Assertio Holdings, Inc. is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through business development including licensing, mergers, and acquisitions. For more information regarding Assertio Holdings, go to: https://www.assertiotx.com/. Investor Contact:Matt KrepsManaging DirectorDarrow AssociatesAustin, TXM: [email protected] \nSource: Assertio Holdings, Inc.","length":3537,"tagName":"div"}]